SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Chia-Yuan Lin, Chia-Wen Tsai, Carnosic Acid Attenuates 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells by Inducing Autophagy Through an Enhanced Interaction of Parkin and Beclin1, Molecular Neurobiology, 2016,

    CrossRef

  2. 2
    Opeyemi J. Olatunji, Yan Feng, Oyenike O. Olatunji, Jian Tang, Zhen Ouyang, Zhaoliang Su, Cordycepin protects PC12 cells against 6-hydroxydopamine induced neurotoxicity via its antioxidant properties, Biomedicine & Pharmacotherapy, 2016, 81, 7

    CrossRef

  3. 3
    Carol Naughton, Niamh Moriarty, Jennifer Feehan, Daniel O'Toole, Eilís Dowd, Differential pattern of motor impairments in neurotoxic, environmental and inflammation-driven rat models of Parkinson’s disease, Behavioural Brain Research, 2016, 296, 451

    CrossRef

  4. 4
    Anthony H.V. Schapira, Davide Chiasserini, Tommaso Beccari, Lucilla Parnetti, Glucocerebrosidase in Parkinson's disease: Insights into pathogenesis and prospects for treatment, Movement Disorders, 2016, 31, 4
  5. 5
    Taku Hatano, Shinji Saiki, Ayami Okuzumi, Robert P Mohney, Nobutaka Hattori, Identification of novel biomarkers for Parkinson's disease by metabolomic technologies, Journal of Neurology, Neurosurgery & Psychiatry, 2016, 87, 3, 295

    CrossRef

  6. 6
    Matthew E. Gegg, Anthony H.V. Schapira, Mitochondrial dysfunction associated with glucocerebrosidase deficiency, Neurobiology of Disease, 2016, 90, 43

    CrossRef

  7. 7
    Md Zeeshan Rasheed, Heena Tabassum, Suhel Parvez, Mitochondrial permeability transition pore: a promising target for the treatment of Parkinson’s disease, Protoplasma, 2016,

    CrossRef

  8. 8
    Mona Sadeghian, Gizem Mullali, Jennifer M. Pocock, Thomas Piers, Arthur Roach, Kenneth J. Smith, Neuroprotection by safinamide in the 6-hydroxydopamine model of Parkinson's disease, Neuropathology and Applied Neurobiology, 2016, 42, 3
  9. 9
    Tanuja Bordia, Xiomara A. Perez, Jaime E. Heiss, Danhui Zhang, Maryka Quik, Optogenetic activation of striatal cholinergic interneurons regulates L-dopa-induced dyskinesias, Neurobiology of Disease, 2016, 91, 47

    CrossRef

  10. 10
    Zahra Kiasalari, Mohsen Khalili, Tourandokht Baluchnejadmojarad, Mehrdad Roghani, Protective Effect of Oral Hesperetin Against Unilateral Striatal 6-Hydroxydopamine Damage in the Rat, Neurochemical Research, 2016, 41, 5, 1065

    CrossRef

  11. 11
    Jing-Yi Zhang, Yong-Ning Deng, Meng Zhang, Hua Su, Qiu-Min Qu, SIRT3 Acts as a Neuroprotective Agent in Rotenone-Induced Parkinson Cell Model, Neurochemical Research, 2016,

    CrossRef

  12. 12
    Dong Gyun Ko, Young Bum Eun, Jong Uk Na, Sang-Tae Kim, Synergistic Effect of Watermelon Powder and <i>Lactococcus lactis</i> subsp <i>lactis</i> Supplemented Diet Partially Ameliorates A<i>β</i>42-Dependent Lifespan Shorten and Flight Impairment in Transgenic <i>Drosophila</i>, American Journal of Plant Sciences, 2016, 07, 06, 991

    CrossRef

  13. 13
    Xiaoliu Dong, Tiejun Liu, Shijun Xu, Lixia Zhu, Panpan Zhang, Aibin Cheng, Qingqiang Qian, The relevance of ABCA1 R219K polymorphisms and serum ABCA1 protein concentration to Parkinson’s disease pathogenesis and classification: a case–control study, Genes & Genomics, 2016, 38, 3, 243

    CrossRef

  14. 14
    Sachchida Nand Rai, Satyndra Kumar Yadav, Divakar Singh, Surya Pratap Singh, Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model, Journal of Chemical Neuroanatomy, 2016, 71, 41

    CrossRef

  15. 15
    Maria João Matos, Fernanda Rodríguez-Enríquez, Fernanda Borges, Lourdes Santana, Eugenio Uriarte, Martín Estrada, María Isabel Rodríguez-Franco, Reyes Laguna, Dolores Viña, 3-Amidocoumarins as Potential Multifunctional Agents against Neurodegenerative Diseases, ChemMedChem, 2015, 10, 12
  16. 16
    Jenny Riecke, Katherine M. Johns, Chunyan Cai, Farhaan Shaheer Vahidy, Kaushik Parsha, Erin Furr-Stimming, Mya Schiess, Sean I. Savitz, A Meta-Analysis of Mesenchymal Stem Cells in Animal Models of Parkinson's Disease, Stem Cells and Development, 2015, 24, 18, 2082

    CrossRef

  17. 17
    Qing Gao, Teng Jiang, Hong-Rui Zhao, Liang Wu, You-Yong Tian, Zhou Ou, Li Zhang, Yang Pan, Jie Lu, Ying-Dong Zhang, Activation of Autophagy Contributes to the Angiotensin II-Triggered Apoptosis in a Dopaminergic Neuronal Cell Line, Molecular Neurobiology, 2015,

    CrossRef

  18. 18
    Hong-Rui Zhao, Teng Jiang, You-Yong Tian, Qing Gao, Zhang Li, Yang Pan, Liang Wu, Jie Lu, Ying-Dong Zhang, Angiotensin II Triggers Apoptosis Via Enhancement of NADPH Oxidase-Dependent Oxidative Stress in a Dopaminergic Neuronal Cell Line, Neurochemical Research, 2015, 40, 4, 854

    CrossRef

  19. 19
    P. Gubellini, P. Kachidian, Animal models of Parkinson's disease: An updated overview, Revue Neurologique, 2015, 171, 11, 750

    CrossRef

  20. 20
    Huan Li, Gunhyuk Park, Nayoung Bae, Joonki Kim, Myung Sook Oh, Hyun Ok Yang, Anti-apoptotic effect of modified Chunsimyeolda-tang, a traditional Korean herbal formula, on MPTP-induced neuronal cell death in a Parkinson's disease mouse model, Journal of Ethnopharmacology, 2015, 176, 336

    CrossRef

  21. 21
    Zhuqin Gu, BinBin Wang, Yong-Biao Zhang, Hui Ding, Yanli Zhang, Jun Yu, Mingliang Gu, Piu Chan, Yanning Cai, Association of ARNTL and PER1 genes with Parkinson's disease: a case-control study of Han Chinese, Scientific Reports, 2015, 5, 15891

    CrossRef

  22. 22
    H. H. Ahmed, F. M. Metwally, W. K. B. Khalil, H. A. Aglan, Bone marrow derived mesenchymal stem cells: A unique cytotherapy for rescuing degenerated dopaminergic neurons, Neurochemical Journal, 2015, 9, 4, 284

    CrossRef

  23. 23
    D. W. Bak, E. Weerapana, Cysteine-mediated redox signalling in the mitochondria, Mol. BioSyst., 2015, 11, 3, 678

    CrossRef

  24. 24
    Dong Gyun Ko, Young Bum Eun, Jong Uk Na, Sang-Tae Kim, Dual PINK Mutant and A<i>β</i>42-Dependent Lifespan Shorten and Flight Impairment in Transgenic Drosophila Partially Alleviates by a <i>Lactococcus lactis</i> Supplemented Diet, Journal of Behavioral and Brain Science, 2015, 05, 07, 266

    CrossRef

  25. 25
    Ling-ru Li, Qi Wang, Ji Wang, Qian-fei Wang, Ling-ling Yang, Lu-yu Zheng, Yan Zhang, Feasibility of assessing health state by detecting redox state of human body based on Chinese medicine constitution, Chinese Journal of Integrative Medicine, 2015,

    CrossRef

  26. 26
    Ling Wang, Lan Cheng, Nan-Nan Li, Wen-Juan Yu, Xiao-Yi Sun, Rong Peng, Genetic analysis of SLC41A1 in Chinese Parkinson's disease patients, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2015, 168, 8
  27. 27
    Anthony H.V. Schapira, Glucocerebrosidase and Parkinson disease: Recent advances, Molecular and Cellular Neuroscience, 2015, 66, 37

    CrossRef

  28. 28
    Tan Wang, Xue-Bin Cao, Xiao-Wu Chen, Pei-Pei Huang, Tian Zhang, Zhi-Bin Chen, Bei-Sha Tang, Influence of simvastatin on dopaminergic neurons of lipopolysaccharide–induced rat model of Parkinson's disease, Asian Pacific Journal of Tropical Medicine, 2015, 8, 1, 64

    CrossRef

  29. 29
    Paolo Calabresi, Veronica Ghiglieri, Petra Mazzocchetti, Ilenia Corbelli, Barbara Picconi, Levodopa-induced plasticity: a double-edged sword in Parkinson's disease?, Philosophical Transactions of the Royal Society B: Biological Sciences, 2015, 370, 1672, 20140184

    CrossRef

  30. 30
    Christine E. Briggs, Yulei Wang, Benjamin Kong, Tsung-Ung W. Woo, Lakshmanan K. Iyer, Kai C. Sonntag, Midbrain dopamine neurons in Parkinson׳s disease exhibit a dysregulated miRNA and target-gene network, Brain Research, 2015, 1618, 111

    CrossRef

  31. 31
    Jun-Jun Zhou, Shen-Yu Zhai, Hui-Nan Zhang, Yue-Hua Wang, Xiao-Ping Pu, Neuroprotective effects of 3-O-demethylswertipunicoside against MPTP-induced Parkinson׳s disease in vivo and its antioxidant properties in vitro, Brain Research, 2015, 1624, 78

    CrossRef

  32. 32
    Aashiq Hussain Bhat, Khalid Bashir Dar, Suhail Anees, Mohammad Afzal Zargar, Akbar Masood, Manzoor Ahmad Sofi, Showkat Ahmad Ganie, Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight, Biomedicine & Pharmacotherapy, 2015, 74, 101

    CrossRef

  33. 33
    Xiomara A. Perez, Preclinical Evidence for a Role of the Nicotinic Cholinergic System in Parkinson’s Disease, Neuropsychology Review, 2015, 25, 4, 371

    CrossRef

  34. 34
    Zhifeng Chen, Ersong Wang, Rong Hu, Yu Sun, Lei Zhang, Jue Jiang, Ying Zhang, Hong Jiang, Tetranectin gene deletion induces Parkinson's disease by enhancing neuronal apoptosis, Biochemical and Biophysical Research Communications, 2015, 468, 1-2, 400

    CrossRef

  35. 35
    Kobra Zare, Akram Eidi, Mehrdad Roghani, Ali Haeri Rohani, The neuroprotective potential of sinapic acid in the 6-hydroxydopamine-induced hemi-parkinsonian rat, Metabolic Brain Disease, 2015, 30, 1, 205

    CrossRef

  36. 36
    Giuseppe Pasqualetti, David J. Brooks, Paul Edison, The Role of Neuroinflammation in Dementias, Current Neurology and Neuroscience Reports, 2015, 15, 4

    CrossRef

  37. 37
    Wenjing Zhang, Haiting An, Feilong Zhang, Lin Dong, Qi Wang, Ruijun Su, Yanjing Qian, Xiaoli Gong, Triptolide Protects Dopaminergic Neurons from 6-OHDA Lesion in a Rat Model of Parkinson's Disease, International Journal of Pharmacology, 2015, 11, 1, 10

    CrossRef

  38. 38
    Jonathan S. Marchant, Sandip Patel, Two-pore channels at the intersection of endolysosomal membrane traffic, Biochemical Society Transactions, 2015, 43, 3, 434

    CrossRef

  39. 39
    Danhui Zhang, Matthew McGregor, Tanuja Bordia, Xiomara A. Perez, J. Michael McIntosh, Michael W. Decker, Maryka Quik, α7 nicotinic receptor agonists reduce levodopa-induced dyskinesias with severe nigrostriatal damage, Movement Disorders, 2015, 30, 14
  40. 40
    Maryka Quik, Tanuja Bordia, Danhui Zhang, Xiomara A. Perez, Nicotine Use in Mental Illness and Neurological Disorders, 2015,

    CrossRef

  41. 41
    David B. Lipsett, Brian E. Staveley, A Blueberry Extract Supplemented Diet Partially Restores <i>α-Synuclein</i>-Dependent Lifespan Loss and Developmental Defects in Drosophila, Advances in Parkinson's Disease, 2014, 03, 02, 3

    CrossRef

  42. 42
    Marc Cuesta, Juliet Aungier, A. Jennifer Morton, Behavioral therapy reverses circadian deficits in a transgenic mouse model of Huntington's disease, Neurobiology of Disease, 2014, 63, 85

    CrossRef

  43. 43
    Jose A. Adams, Arkady Uryash, Jorge Bassuk, Marvin A. Sackner, Paul Kurlansky, Biological basis of neuroprotection and neurotherapeutic effects of Whole Body Periodic Acceleration (pGz), Medical Hypotheses, 2014, 82, 6, 681

    CrossRef

  44. 44
    M.J. Bonifácio, J.S. Sutcliffe, L. Torrão, L.C. Wright, P. Soares-da-Silva, Brain and peripheral pharmacokinetics of levodopa in the cynomolgus monkey following administration of opicapone, a third generation nitrocatechol COMT inhibitor, Neuropharmacology, 2014, 77, 334

    CrossRef

  45. 45
    Franziska Richter, Fuying Gao, Vera Medvedeva, Patrick Lee, Nicholas Bove, Sheila M. Fleming, Magali Michaud, Vincent Lemesre, Stefano Patassini, Krystal De La Rosa, Caitlin K. Mulligan, Pedrom C. Sioshansi, Chunni Zhu, Giovanni Coppola, Thierry Bordet, Rebecca M. Pruss, Marie-Françoise Chesselet, Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons, Neurobiology of Disease, 2014, 69, 263

    CrossRef

  46. 46
    Beatriz Raposo Corradini, Priscila Iamashita, Edilaine Tampellini, José Marcelo Farfel, Lea Tenenholz Grinberg, Carlos Alberto Moreira-Filho, Complex Network-Driven View of Genomic Mechanisms Underlying Parkinson’s Disease: Analyses in Dorsal Motor Vagal Nucleus, Locus Coeruleus, and Substantia Nigra, BioMed Research International, 2014, 2014, 1

    CrossRef

  47. 47
    Anne-Marie Arel-Dubeau, Fanny Longpré, Julie Bournival, Cindy Tremblay, Julie Demers-Lamarche, Pavlina Haskova, Everaldo Attard, Marc Germain, Maria-Grazia Martinoli, Cucurbitacin E Has Neuroprotective Properties and Autophagic Modulating Activities on Dopaminergic Neurons, Oxidative Medicine and Cellular Longevity, 2014, 2014, 1

    CrossRef

  48. 48
    Paolo Gubellini, Christophe Melon, Elena Dale, Dario Doller, Lydia Kerkerian-Le Goff, Distinct effects of mGlu4 receptor positive allosteric modulators at corticostriatal vs. striatopallidal synapses may differentially contribute to their antiparkinsonian action, Neuropharmacology, 2014, 85, 166

    CrossRef

  49. 49
    Cheng-long Xie, Jia-Lin Pan, Su-fang Zhang, Jing Gan, Zhen-Guo Liu, Effect of nicotine on l-dopa-induced dyskinesia in animal models of Parkinson’s disease: a systematic review and meta-analysis, Neurological Sciences, 2014, 35, 5, 653

    CrossRef

  50. 50
    Maria Antonietta De Luca, Omar Cauli, Micaela Morelli, Nicola Simola, Elevation of striatal urate in experimental models of Parkinson's disease: a compensatory mechanism triggered by dopaminergic nigrostriatal degeneration?, Journal of Neurochemistry, 2014, 131, 3
  51. 51
    J. Jamshidi, A. Movafagh, B. Emamalizadeh, A. Zare Bidoki, A. Manafi, S. Ghasemi Firouzabadi, G.-A. Shahidi, S. Kazeminasab, P. Petramfar, A. Fazeli, M. Motallebi, S. A. Mortazavi-Tabatabaei, A. Kowsari, Z. Jafarian, H. Darvish, HLA-DRA is associated with Parkinson's disease in Iranian population, International Journal of Immunogenetics, 2014, 41, 6
  52. 52
    Harm J. Heusinkveld, Martin van den Berg, Remco H.S. Westerink, In vitrodopaminergic neurotoxicity of pesticides: a link with neurodegeneration?, Veterinary Quarterly, 2014, 34, 3, 120

    CrossRef

  53. 53
    Mary Ann Chapman, Interactions between cell adhesion and the synaptic vesicle cycle in Parkinson’s disease, Medical Hypotheses, 2014, 83, 2, 203

    CrossRef

  54. 54
    Gabor G. Kovacs, Leonid Breydo, Ryan Green, Viktor Kis, Gina Puska, Péter Lőrincz, Laura Perju-Dumbrava, Regina Giera, Walter Pirker, Mirjam Lutz, Ingolf Lachmann, Herbert Budka, Vladimir N. Uversky, Kinga Molnár, Lajos László, Intracellular processing of disease-associated α-synuclein in the human brain suggests prion-like cell-to-cell spread, Neurobiology of Disease, 2014, 69, 76

    CrossRef

  55. 55
    Karim Fifel, Howard M. Cooper, Loss of dopamine disrupts circadian rhythms in a mouse model of Parkinson's disease, Neurobiology of Disease, 2014, 71, 359

    CrossRef

  56. 56
    Woori Kim, Yenarae Lee, Noah D. McKenna, Ming Yi, Filip Simunovic, Yulei Wang, Benjamin Kong, Robert J. Rooney, Hyemyung Seo, Robert M. Stephens, Kai C. Sonntag, miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling, Neurobiology of Aging, 2014, 35, 7, 1712

    CrossRef

  57. 57
    Fabiana Morroni, Giulia Sita, Andrea Tarozzi, Giorgio Cantelli-Forti, Patrizia Hrelia, Neuroprotection by 6-(methylsulfinyl)hexyl isothiocyanate in a 6-hydroxydopamine mouse model of Parkinson׳s disease, Brain Research, 2014, 1589, 93

    CrossRef

  58. 58
    Ramavati Pal, Guido Alves, Jan Petter Larsen, Simon Geir Møller, New Insight into Neurodegeneration: the Role of Proteomics, Molecular Neurobiology, 2014, 49, 3, 1181

    CrossRef

  59. 59
    Frédéric Checler, Cristine Alves da Costa, p53 in neurodegenerative diseases and brain cancers, Pharmacology & Therapeutics, 2014, 142, 1, 99

    CrossRef

  60. 60
    Maxime Assous, Laurence Had-Aissouni, Paolo Gubellini, Christophe Melon, Imane Nafia, Pascal Salin, Lydia Kerkerian-Le-Goff, Philippe Kachidian, Progressive Parkinsonism by acute dysfunction of excitatory amino acid transporters in the rat substantia nigra, Neurobiology of Disease, 2014, 65, 69

    CrossRef

  61. 61
    Zhan Gao, Hong-Juan Fu, Ju-Jun Xue, Zhi-Xuan Wu, Li-Bo Zhao, RETRACTED ARTICLE: Genetic polymorphisms in VDR, ESR1 and ESR2 genes may contribute to susceptibility to Parkinson’s disease: a meta-analysis, Molecular Biology Reports, 2014, 41, 7, 4463

    CrossRef

  62. 62
    Bingwei Lu, Stephan Gehrke, Zhihao Wu, RNA metabolism in the pathogenesis of Parkinson׳s disease, Brain Research, 2014, 1584, 105

    CrossRef

  63. 63
    Maryka Quik, Danhui Zhang, Xiomara A. Perez, Tanuja Bordia, Role for the nicotinic cholinergic system in movement disorders; therapeutic implications, Pharmacology & Therapeutics, 2014, 144, 1, 50

    CrossRef

  64. 64
    Se-Eun Park, Kumar Sapkota, Jun-Hui Choi, Myung-Kon Kim, Young Hoi Kim, Ki Man Kim, Kyung Je Kim, Ha-Na Oh, Sung-Jun Kim, Seung Kim, Rutin from Dendropanax morbifera Leveille Protects Human Dopaminergic Cells Against Rotenone Induced Cell Injury Through Inhibiting JNK and p38 MAPK Signaling, Neurochemical Research, 2014, 39, 4, 707

    CrossRef

  65. 65
    Anmu Xie, Jing Gao, Lin Xu, Dongmei Meng, Shared Mechanisms of Neurodegeneration in Alzheimer’s Disease and Parkinson’s Disease, BioMed Research International, 2014, 2014, 1

    CrossRef

  66. 66
    Behrang Alani, Rasoul Salehi, Payam Sadeghi, Mohammad Zare, Fariba Khodagholi, Ehsan Arefian, Mazdak Ganjalikhani Hakemi, Hadi Digaleh, Silencing of Hsp90 Chaperone Expression Protects Against 6-Hydroxydopamine Toxicity in PC12 Cells, Journal of Molecular Neuroscience, 2014, 52, 3, 392

    CrossRef

  67. 67
    Maria João Matos, Patricia Janeiro, Rosa María González Franco, Santiago Vilar, Nicholas P Tatonetti, Lourdes Santana, Eugenio Uriarte, Fernanda Borges, José Angel Fontenla, Dolores Viña, Synthesis, pharmacological study and docking calculations of new benzo[f]coumarin derivatives as dual inhibitors of enzymatic systems involved in neurodegenerative diseases, Future Medicinal Chemistry, 2014, 6, 4, 371

    CrossRef

  68. 68
    Kurt A Jellinger, The pathomechanisms underlying Parkinson's disease, Expert Review of Neurotherapeutics, 2014, 14, 2, 199

    CrossRef

  69. 69
    Omid Tavassoly, Joe Kakish, Sergiy Nokhrin, Oleg Dmitriev, Jeremy S. Lee, The use of nanopore analysis for discovering drugs which bind to α-synuclein for treatment of Parkinson's disease, European Journal of Medicinal Chemistry, 2014, 88, 42

    CrossRef

  70. 70
    Clare Finlay, Susan Duty, Therapeutic potential of targeting glutamate receptors in Parkinson’s disease, Journal of Neural Transmission, 2014, 121, 8, 861

    CrossRef

  71. 71
    Chih-Hsin Lin, Yih-Ru Wu, Wan-Ling Chen, Hao-Chun Wang, Chi-Mei Lee, Guey-Jen Lee-Chen, Chiung-Mei Chen, Variant R244H in Na+/Mg2+ exchanger SLC41A1 in Taiwanese Parkinson's disease is associated with loss of Mg2+ efflux function, Parkinsonism & Related Disorders, 2014, 20, 6, 600

    CrossRef

  72. 72
    Peter A. LeWitt, Jia Li, Mei Lu, Thomas G. Beach, Charles H. Adler, Lining Guo, 3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis, Movement Disorders, 2013, 28, 12
  73. 73
    Roger A. Barker, Mark Stacy, Patrik Brundin, A new approach to disease-modifying drug trials in Parkinson’s disease, Journal of Clinical Investigation, 2013, 123, 6, 2364

    CrossRef

  74. 74
    Ilse S. Pienaar, Wilma van de Berg, A non-cholinergic neuronal loss in the pedunculopontine nucleus of toxin-evoked Parkinsonian rats, Experimental Neurology, 2013, 248, 213

    CrossRef

  75. 75
    Mohammadreza Jalali-Nadoushan, Mehrdad Roghani, Alpha-lipoic acid protects against 6-hydroxydopamine-induced neurotoxicity in a rat model of hemi-parkinsonism, Brain Research, 2013, 1505, 68

    CrossRef

  76. 76
    Katrin Beyer, Aurelio Ariza, Alpha-Synuclein Posttranslational Modification and Alternative Splicing as a Trigger for Neurodegeneration, Molecular Neurobiology, 2013, 47, 2, 509

    CrossRef

  77. 77
    Stefania Romeo, Cristina Viaggi, Daniela Di Camillo, Allison W. Willis, Luca Lozzi, Cristina Rocchi, Marta Capannolo, Gabriella Aloisi, Francesca Vaglini, Rita Maccarone, Matteo Caleo, Cristina Missale, Brad A. Racette, Giovanni U. Corsini, Roberto Maggio, Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson's disease epidemiology, Scientific Reports, 2013, 3,

    CrossRef

  78. 78
    Yong-Ning Deng, Jie Shi, Jie Liu, Qiu-Min Qu, Celastrol protects human neuroblastoma SH-SY5Y cells from rotenone-induced injury through induction of autophagy, Neurochemistry International, 2013, 63, 1, 1

    CrossRef

  79. 79
    Udo Rüb, Ludger Schöls, Henry Paulson, Georg Auburger, Pawel Kermer, Joanna C. Jen, Kay Seidel, Horst-Werner Korf, Thomas Deller, Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7, Progress in Neurobiology, 2013, 104, 38

    CrossRef

  80. 80
    Martine Besouw, Rosalinde Masereeuw, Lambert van den Heuvel, Elena Levtchenko, Cysteamine: an old drug with new potential, Drug Discovery Today, 2013, 18, 15-16, 785

    CrossRef

  81. 81
    Brian P. Dranka, Alison Gifford, Anamitra Ghosh, Jacek Zielonka, Joy Joseph, Anumantha G. Kanthasamy, Balaraman Kalyanaraman, Diapocynin prevents early Parkinson's disease symptoms in the leucine-rich repeat kinase 2 (LRRK2R1441G) transgenic mouse, Neuroscience Letters, 2013, 549, 57

    CrossRef

  82. 82
    Ahmed Sharaf, Kerstin Krieglstein, Björn Spittau, Distribution of microglia in the postnatal murine nigrostriatal system, Cell and Tissue Research, 2013, 351, 3, 373

    CrossRef

  83. 83
    A. A. Inamdar, M. M. Hossain, A. I. Bernstein, G. W. Miller, J. R. Richardson, J. W. Bennett, Fungal-derived semiochemical 1-octen-3-ol disrupts dopamine packaging and causes neurodegeneration, Proceedings of the National Academy of Sciences, 2013, 110, 48, 19561

    CrossRef

  84. 84
    Yong Ping Chen, Wei Song, Rui Huang, Ke Chen, Bi Zhao, Jianpeng Li, Yuan Yang, Hui-Fang Shang, GAK rs1564282 and DGKQ rs11248060 increase the risk for Parkinson’s disease in a Chinese population, Journal of Clinical Neuroscience, 2013, 20, 6, 880

    CrossRef

  85. 85
    Yi-Chun Chen, Yih-Ru Wu, Yi-Ci Wu, Guey-Jen Lee-Chen, Chiung-Mei Chen, Genetic analysis of NFE2L2 promoter variation in Taiwanese Parkinson's disease, Parkinsonism & Related Disorders, 2013, 19, 2, 247

    CrossRef

  86. 86
    Dongfeng Chen, Shuchao Pang, Xungang Feng, Wenhui Huang, Robert G. Hawley, Bo Yan, Genetic analysis of the ATG7 gene promoter in sporadic Parkinson's disease, Neuroscience Letters, 2013, 534, 193

    CrossRef

  87. 87
    Koji Aoyama, Toshio Nakaki, Impaired Glutathione Synthesis in Neurodegeneration, International Journal of Molecular Sciences, 2013, 14, 10, 21021

    CrossRef

  88. 88
    Jamal Elkharaz, Aslihan Ugun-Klusek, Dumitru Constantin-Teodosiu, Karen Lawler, R John Mayer, Ellen Billett, James Lowe, Lynn Bedford, Implications for oxidative stress and astrocytes following 26S proteasomal depletion in mouse forebrain neurones, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013, 1832, 12, 1930

    CrossRef

  89. 89
    S. Iannaccone, C. Cerami, M. Alessio, V. Garibotto, A. Panzacchi, S. Olivieri, G. Gelsomino, R.M. Moresco, D. Perani, In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease, Parkinsonism & Related Disorders, 2013, 19, 1, 47

    CrossRef

  90. 90
    Karim Fifel, Ouria Dkhissi-Benyahya, Howard M. Cooper, Lack of long-term changes in circadian, locomotor, and cognitive functions in acute and chronic MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse models of parkinson’s disease, Chronobiology International, 2013, 30, 6, 741

    CrossRef

  91. 91
    Stéphanie Simoni, Dominique Linard, Emmanuel Hermans, Bernard Knoops, Julie Goemaere, Mitochondrial peroxiredoxin-5 as potential modulator of mitochondria-ER crosstalk in MPP+-induced cell death, Journal of Neurochemistry, 2013, 125, 3
  92. 92
    Karen Freimann, Katja Zschiedrich, Norbert Brüggemann, Anne Grünewald, Heike Pawlack, Johann Hagenah, Katja Lohmann, Christine Klein, Ana Westenberger, Mortalin mutations are not a frequent cause of early-onset Parkinson disease, Neurobiology of Aging, 2013, 34, 11, 2694.e19

    CrossRef

  93. 93
    Chin-Hsien Lin, Meng-Ling Chen, Tzu-Ting Lai, Chun-Hwei Tai, Ruey-Meei Wu, Mutational analysis of FBXO7 gene in Parkinson's disease in a Taiwanese population, Neurobiology of Aging, 2013, 34, 6, 1713.e1

    CrossRef

  94. 94
    David Sulzer, D. James Surmeier, Neuronal vulnerability, pathogenesis, and Parkinson's disease, Movement Disorders, 2013, 28, 6
  95. 95
    David Sulzer, D. James Surmeier, Neuronal vulnerability, pathogenesis, and Parkinson's disease, Movement Disorders, 2013, 28, 1
  96. 96
    Maryka Quik, Archana Mallela, Matthew Chin, J. Michael McIntosh, Xiomara A. Perez, Tanuja Bordia, Nicotine-mediated improvement in l-dopa-induced dyskinesias in MPTP-lesioned monkeys is dependent on dopamine nerve terminal function, Neurobiology of Disease, 2013, 50, 30

    CrossRef

  97. 97
    David T. Dexter, Peter Jenner, Parkinson disease: from pathology to molecular disease mechanisms, Free Radical Biology and Medicine, 2013, 62, 132

    CrossRef

  98. 98
    Sara Mínguez-Mínguez, Julián Solís-García del Pozo, Joaquín Jordán, Rasagiline in Parkinson's disease: A review based on meta-analysis of clinical data, Pharmacological Research, 2013, 74, 78

    CrossRef

  99. 99
    Rita Perfeito, Teresa Cunha-Oliveira, Ana Cristina Rego, Reprint of: Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease—resemblance to the effect of amphetamine drugs of abuse, Free Radical Biology and Medicine, 2013, 62, 186

    CrossRef

  100. 100
    Onyou Hwang, Role of Oxidative Stress in Parkinson's Disease, Experimental Neurobiology, 2013, 22, 1, 11

    CrossRef

  101. 101
    Julius V. Emmrich, Tamara C. Hornik, Jonas J. Neher, Guy C. Brown, Rotenone induces neuronal death by microglial phagocytosis of neurons, The FEBS Journal, 2013, 280, 20
  102. 102
    Yongsheng Yuan, Qing Tong, Xianju Zhou, Rui Zhang, Zhiqiang Qi, Kezhong Zhang, The association between glycogen synthase kinase 3 beta polymorphisms and Parkinson's disease susceptibility: A meta-analysis, Gene, 2013, 524, 2, 133

    CrossRef

  103. 103
    Tanuja Bordia, J. Michael McIntosh, Maryka Quik, The nicotine-mediated decline in l-dopa-induced dyskinesias is associated with a decrease in striatal dopamine release, Journal of Neurochemistry, 2013, 125, 2
  104. 104
    Eva-Maria Hanschmann, José Rodrigo Godoy, Carsten Berndt, Christoph Hudemann, Christopher Horst Lillig, Thioredoxins, Glutaredoxins, and Peroxiredoxins—Molecular Mechanisms and Health Significance: from Cofactors to Antioxidants to Redox Signaling, Antioxidants & Redox Signaling, 2013, 19, 13, 1539

    CrossRef

  105. 105
    Christopher J.R. Dunning, Sonia George, Patrik Brundin, What’s to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?, Prion, 2013, 7, 1, 92

    CrossRef

  106. 106
    Maryka Quik, Carla Campos, Tanuja Bordia, Jon-Paul Strachan, Jenny Zhang, J. Michael McIntosh, Sharon Letchworth, Kristen Jordan, α4β2 nicotinic receptors play a role in the nAChR-mediated decline in l-dopa-induced dyskinesias in parkinsonian rats, Neuropharmacology, 2013, 71, 191

    CrossRef

  107. 107
    Bai-Yun Zeng, Sarah Salvage, Peter Jenner, Neurobiology of Acupuncture, 2013,

    CrossRef

  108. 108
    Shankar J. Chinta, Subramanian Rajagopalan, Abirami Ganesan, Julie K. Andersen, A Possible Novel Anti-Inflammatory Mechanism for the Pharmacological Prolyl Hydroxylase Inhibitor 3,4-Dihydroxybenzoate: Implications for Use as a Therapeutic for Parkinson’s Disease, Parkinson's Disease, 2012, 2012, 1

    CrossRef

  109. 109
    Brian P. Dranka, Jacek Zielonka, Anumantha G. Kanthasamy, Balaraman Kalyanaraman, Alterations in bioenergetic function induced by Parkinson’s disease mimetic compounds: lack of correlation with superoxide generation, Journal of Neurochemistry, 2012, 122, 5
  110. 110
    Oscar S. Gershanik, Are we ready for a new definition of Parkinson’s disease?, Basal Ganglia, 2012, 2, 2, 55

    CrossRef

  111. 111
    Bi Zhao, Wei Song, Yong Ping Chen, Rui Huang, Ke Chen, Bei Cao, Yuan Yang, Hui-Fang Shang, Association Analysis of Single-Nucleotide Polymorphisms of USP24 and USP40 with Parkinson’s Disease in the Han Chinese Population, European Neurology, 2012, 68, 3, 181

    CrossRef

  112. 112
    Ke Chen, Yong Ping Chen, Wei Song, Rui Huang, Bi Zhao, Bei Cao, Yuan Yang, Wataru Satake, Tatsushi Toda, Hui-Fang Shang, Association analysis ofLRP8SNP rs3820198 and rs5174 with Parkinson’s disease in Han Chinese population, Neurological Research, 2012, 34, 7, 725

    CrossRef

  113. 113
    Maria G. Cersosimo, Eduardo E. Benarroch, Autonomic involvement in Parkinson's disease: Pathology, pathophysiology, clinical features and possible peripheral biomarkers, Journal of the Neurological Sciences, 2012, 313, 1-2, 57

    CrossRef

  114. 114
    Graham R. Campbell, Yevgenya Kraytsberg, Kim J. Krishnan, Nobuhiko Ohno, Iryna Ziabreva, Amy Reeve, Bruce D. Trapp, Jia Newcombe, Richard Reynolds, Hans Lassmann, Konstantin Khrapko, Doug M. Turnbull, Don J. Mahad, Clonally expanded mitochondrial DNA deletions within the choroid plexus in multiple sclerosis, Acta Neuropathologica, 2012, 124, 2, 209

    CrossRef

  115. 115
    Dominic J. Hare, Manfred Gerlach, Peter Riederer, Considerations for measuring iron in post-mortem tissue of Parkinson’s disease patients, Journal of Neural Transmission, 2012, 119, 12, 1515

    CrossRef

  116. 116
    Gabriela Lopez-Herrera, Giacomo Tampella, Qiang Pan-Hammarström, Peer Herholz, Claudia M. Trujillo-Vargas, Kanchan Phadwal, Anna Katharina Simon, Michel Moutschen, Amos Etzioni, Adi Mory, Izhak Srugo, Doron Melamed, Kjell Hultenby, Chonghai Liu, Manuela Baronio, Massimiliano Vitali, Pierre Philippet, Vinciane Dideberg, Asghar Aghamohammadi, Nima Rezaei, Victoria Enright, Likun Du, Ulrich Salzer, Hermann Eibel, Dietmar Pfeifer, Hendrik Veelken, Hans Stauss, Vassilios Lougaris, Alessandro Plebani, E. Michael Gertz, Alejandro A. Schäffer, Lennart Hammarström, Bodo Grimbacher, Deleterious Mutations in LRBA Are Associated with a Syndrome of Immune Deficiency and Autoimmunity, The American Journal of Human Genetics, 2012, 90, 6, 986

    CrossRef

  117. 117
    Patricia Rojas, Pedro Montes, Carolina Rojas, Norma Serrano-García, Julio César Rojas-Castañeda, Effect of a phytopharmaceutical medicine, Ginko biloba extract 761, in an animal model of Parkinson's disease: Therapeutic perspectives, Nutrition, 2012, 28, 11-12, 1081

    CrossRef

  118. 118
    Jonathan L. Brigman, Elizabeth M. Powell, Guy Mittleman, Jared W. Young, Examining the genetic and neural components of cognitive flexibility using mice, Physiology & Behavior, 2012, 107, 5, 666

    CrossRef

  119. 119
    Wei Song, Yong Ping Chen, Rui Huang, Ke Chen, Ping Lei Pan, Jianpeng Li, Yuan Yang, Hui-Fang Shang, GLIS1rs797906: An Increased Risk Factor for Late-Onset Parkinson’s Disease in the Han Chinese Population, European Neurology, 2012, 68, 2, 89

    CrossRef

  120. 120
    Ya-xing Gui, Xiao-ning Fan, Hong-mei Wang, Gang Wang, Sheng-di Chen, Glyphosate induced cell death through apoptotic and autophagic mechanisms, Neurotoxicology and Teratology, 2012, 34, 3, 344

    CrossRef

  121. 121
    Xiaoyu Sun, Zhongkui Xiong, Yongfang Zhang, Ya Meng, Gang Xu, Zhiming Xia, Jiamei Li, Rui Zhang, Zunji Ke, Zongqin Xia, Yaer Hu, Harpagoside attenuates MPTP/MPP+ induced dopaminergic neurodegeneration and movement disorder via elevating glial cell line-derived neurotrophic factor, Journal of Neurochemistry, 2012, 120, 6
  122. 122
    Hansen Wang, Laurie C. Doering, Induced Pluripotent Stem Cells to Model and Treat Neurogenetic Disorders, Neural Plasticity, 2012, 2012, 1

    CrossRef

  123. 123
    Hyemin Kim, June-Hee Park, Kyungjin Kim, Lipid-like components released from degenerating dopaminergic neurons trigger the dynamic migration of microglia, Biochemical and Biophysical Research Communications, 2012, 426, 1, 18

    CrossRef

  124. 124
    B. Dehay, A. Ramirez, M. Martinez-Vicente, C. Perier, M.-H. Canron, E. Doudnikoff, A. Vital, M. Vila, C. Klein, E. Bezard, Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration, Proceedings of the National Academy of Sciences, 2012, 109, 24, 9611

    CrossRef

  125. 125
    Peter Jenner, Mitochondria, monoamine oxidase B and Parkinson’s disease, Basal Ganglia, 2012, 2, 4, S3

    CrossRef

  126. 126
    Maryka Quik, Xiomara A. Perez, Tanuja Bordia, Nicotine as a potential neuroprotective agent for Parkinson's disease, Movement Disorders, 2012, 27, 8
  127. 127
    Patricia Muñoz, Sandro Huenchuguala, Irmgard Paris, Carlos Cuevas, Monica Villa, Pablo Caviedes, Juan Segura-Aguilar, Yousef Tizabi, Protective Effects of Nicotine Against Aminochrome-Induced Toxicity in Substantia Nigra Derived Cells: Implications for Parkinson’s Disease, Neurotoxicity Research, 2012, 22, 2, 177

    CrossRef

  128. 128
    Azza Ismail, Ke Ning, Abdulmonem Al-Hayani, Basil Sharrack, Mimoun Azzouz, PTEN: A molecular target for neurodegenerative disorders, Translational Neuroscience, 2012, 3, 2

    CrossRef

  129. 129
    Rita Perfeito, Teresa Cunha-Oliveira, Ana Cristina Rego, Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease—resemblance to the effect of amphetamine drugs of abuse, Free Radical Biology and Medicine, 2012, 53, 9, 1791

    CrossRef

  130. 130
    Maryka Quik, Keon Min Park, Maya Hrachova, Archana Mallela, Luping Z. Huang, J. Michael McIntosh, Sharon R. Grady, Role for α6 nicotinic receptors in l-dopa-induced dyskinesias in parkinsonian mice, Neuropharmacology, 2012, 63, 3, 450

    CrossRef

  131. 131
    B.A. Morrow, R.H. Roth, D.E. Redmond, S. Diano, J.D. Elsworth, Susceptibility to a parkinsonian toxin varies during primate development, Experimental Neurology, 2012, 235, 1, 273

    CrossRef

  132. 132
    Susan Duty, Targeting Glutamate Receptors to Tackle the Pathogenesis, Clinical Symptoms and Levodopa-Induced Dyskinesia Associated with Parkinson’s Disease, CNS Drugs, 2012, 26, 12, 1017

    CrossRef

  133. 133
    Michael J. Surace, Michelle L. Block, Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors, Cellular and Molecular Life Sciences, 2012, 69, 14, 2409

    CrossRef

  134. 134
    Pabla Aguirre, Pamela Urrutia, Victoria Tapia, Monica Villa, Irmgad Paris, Juan Segura-Aguilar, Marco T. Núñez, The dopamine metabolite aminochrome inhibits mitochondrial complex I and modifies the expression of iron transporters DMT1 and FPN1, BioMetals, 2012, 25, 4, 795

    CrossRef

  135. 135
    Alberto J Espay, Alfonso Fasano, Francesca Morgante, The six gaps in the search of neuroprotection for Parkinson’s disease, Expert Review of Neurotherapeutics, 2012, 12, 2, 111

    CrossRef

  136. 136
    Michael J. Hurley, David T. Dexter, Voltage-gated calcium channels and Parkinson's disease, Pharmacology & Therapeutics, 2012, 133, 3, 324

    CrossRef